Tobramycin Injection (Tobra-day®)

Each vial of Tobra-day contains tobramycin sulfate equivalent to 500 mg tobramycin base in water for injections to 5 mL. Sulfuric acid and sodium hydroxide may be added to adjust pH. Contains no preservatives.

Indication:
For once daily intravenous use in the treatment of cystic fibrosis patients (>5 years old) with acute pulmonary exacerbations caused by susceptible organisms.